The use of a complex of peptides for the treatment of age-related diseases
Background
Today one of the priority directions in Russian anti-aging medicine is а complex application of low mo
lecular weight peptides, which correct errors in the genome. Studies of the past four decades show
the efficiency of medication containing peptides in preventing premature ageing and increasing active
longevity. Today, anti-aging medicine is а complex of measures aimed at synchronous debugging of all
organs and systems that allows а pronounced and lasting effect of revitalization.
This allows us to amend the individual revitalization programs to prevent genetically determined diseases,
which develop mainly in the second half of life (atherosclerosis, varicose veins, osteoporosis, diabetes
mellitus, and others). Russian Society of Anti-aging Medicine is actively working on the revision of the
doctrine of revitalization, which existed for many years, developing new advanced schemes of application
of medication.
We invent complex programs of correction of the body’s functioning with peptide medication in case of
age-related pathologies.
Today, we declare again that our body is а system that requires а systematic approach to maintaining the
body’s functions.
So it’s time to share clinical experience in applying the whole system of peptide medication in treating
cerebral atherosclerosis and diabetes mellitus type 2.
Methods
We conducted а study of the effectiveness of treatment in 1249 patients with cerebral atherosclerosis
aged between 55-65 years. We excluded patients with traumatic brain injuries, with a history of having
strokes, and patients receiving statin medications. The study of the effectiveness of the peptide complex
used to treat cerebral atherosclerosis was conducted in December 2011 — June 2012 in the Moscow
office of the Center of Revitalization and Health.
All patients were The first group: 514 people who received standard treatment
following the conventional scheme.divided into 1
3 groups: The second group: 319 people who received a complex which
contains blood vessel peptides Ventfort and а complex con
taining brain peptides Cerluten in addition to the standard 2
scheme of treatment.
The third group: 416 people who received а peptide complex,
which included: a complex containing pineal gland peptides
Endoluten, a complex containing liver peptides Svetinorm, 3
a complex containing blood vessel peptides Ventfort, and а
complex containing brain peptides Cerluten in addition to the
standard scheme of treatment.
The rationale for this study is based оn the data provided bу the study of the effectiveness of the medical
products obtained previously. All products containing peptides used in the study are developed bу the
St. Petersburg Institute of Bioregulation and Gerontology and are essentially complexes of low molecular
weight peptides with а molecular weight up to 5000 Da, isolated from organs and tissues of young animals.
Seoul, South Korea 2013
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.